Drive DeVilbiss Healthcare acquires product line of De Oro Devices

By HME News Staff
Updated 9:23 AM CDT, Thu June 19, 2025

PORT WASHINGTON, N.Y. – Drive DeVilbiss Healthcare (DDH) has acquired the product line of De Oro Devices, the California-based company behind NexStride, a mobility aid designed to help people with Parkinson’s disease and other mobility-limiting conditions walk with greater safety and confidence.
Founded in 2018, De Oro Devices launched NexStride as a clip-on cueing device to support mobility and physical activity for people with neuroambulatory disorders. About the size of a deck of cards, NexStride easily attaches to any cane, walker, or rollator and provides both visual and auditory cues—a laser line and a customizable metronome—that help re-establish the brain-body connection during walking.
Originally developed to address freezing of gait (FoG) in Parkinson’s disease, NexStride is now used by individuals with multiple sclerosis, cerebral palsy and other conditions, as well as those suffering from the effects of stroke. The device is available in seven countries, including the United States, where it is offered through the U.S. Veterans Health Administration and other distribution channels.
“NexStride shows how smart, research-backed technology can help people with neuroambulatory disorders stay active, live more independently and potentially avoid complications,” said Derek Lampert, CEO of Drive DeVilbiss Healthcare. “We’re proud to help bring this innovative solution to more people who need it.”
As part of the acquisition, Sidney Collin, cofounder of De Oro Devices and inventor of NexStride, will join the company as clinical vice president – product management, leading the development of the NexStride product roadmap, navigating coverage pathways and heading up access initiatives to help more people benefit from the technology.
“This milestone is the culmination of years of dedication to a simple idea: That everyone deserves to walk with dignity and confidence,” said Collin. “Partnering with DDH means NexStride can now reach people faster and with greater support behind it. I’m deeply grateful to our team, our investors and especially to the Parkinson’s community that inspired and informed every step of our journey.”
Comments